Therefore, in order to further understand the incidence of BRCA1/2 gene mutations in Chinese ovarian cancer patients and the relationship with clinicopathological factors, we conducted a retrospective study to further explore the role of BRCA1/2 gene mutations in ovarian cancer. This evidence concerns the gene BRCA1 and ovarian cancer.